Business Wire

CA-TALKDESK

4.8.2022 11:32:06 CEST | Business Wire | Press release

Share
SD Worx Chooses Talkdesk Contact Center Solution

Talkdesk®, Inc. , a global contact center leader for customer-obsessed companies, and Microsoft are partnering to deliver a contact center solution for SD Worx . The leading European provider of people solutions selected Talkdesk with Microsoft Teams Connector because it will provide a future-proof platform with enhanced stability to support better customer experiences (CX) through richer agent collaborations.

With headquarters in Belgium, SD Worx has been delivering people solutions across the entire employee lifecycle for more than 75 years. Turning human resources (HR) into a source of value for their more than 80,000 clients across 150 plus countries worldwide, company leaders believe people are at the heart of any business success. SD Worx is driven by a desire to see not only their own global workforce of nearly 7,000 thrive and spark success, but also the five million plus employees they serve each month.

The existing SD Worx contact center operates with separate telephony and case management platforms. Those separate platforms, paired with a combined inbound and outbound volume of more than a million client calls each year, make the process for agents trying to simultaneously gather client insights and field client queries complicated. Talkdesk CX Cloud™, an end-to-end customer experience solution, will provide SD Worx with a modernized, cloud-based contact center platform that can grow with the company.

Additionally, Talkdesk Microsoft Teams Connector™ will enable deeper collaboration between contact center agents and other teams across the organization. Talkdesk for Salesforce™ will further streamline operations and enhance opportunities for personalized engagement across channels. The Talkdesk solution – providing deep integrations with these key platforms – will allow SD Worx agents to more proactively support clients with increased efficiency.

“When we design our contact center flows, I always try to picture myself as one of our clients,” said Yannick Lefever, product owner, SD Worx. “CX comes first here. It’s important to us that the whole customer journey is positive and productive from inquiry to conclusion, and the little details can make or break that experience for all involved. The Talkdesk solution will provide a more seamless experience for SD Worx agents and clients, ensuring that all those details align across platforms and customer touch points.”

“At Microsoft, we strive to exceed customer expectations,” said Mauro Xavier, general manager for partnership solutions, Microsoft. “Partnerships like the one we have with Talkdesk allow us to do exactly that. By integrating best in breed software – Talkdesk CX Cloud and Microsoft Teams – we were able to provide a unique value proposition to SD Worx, enhancing collaboration and enabling a better user experience.”

“For any industry – and especially people solutions – a successful, customer-centric approach to contact center operations hinges on the ability for departments, teams, and individual contact center agents to collaborate seamlessly,” said Tiago Paiva, chief executive officer, Talkdesk. “With the Talkdesk solution, SD Worx is prioritizing the kinds of collaborations across platforms that spark success among contact center agents, and translate to faster issue resolution for clients. We’re proud to partner with Microsoft and SD Worx to deliver exceptional CX for millions of employees every month.”

Additional Resources

Social Networks

About Talkdesk

Talkdesk® is a global cloud contact center leader for customer-obsessed companies. Our automation-first customer experience solutions optimize our customers’ most critical customer service processes. Our speed of innovation, vertical expertise, and global footprint reflect our commitment to ensuring that businesses can deliver better experiences across any industry and through any channel, resulting in higher customer satisfaction and accelerated business outcomes.

Talkdesk is a registered trademark of Talkdesk, Inc. All product and company names are trademarks™ or registered ® trademarks of their respective holders. Use of them does not imply any affiliation or endorsement by them.

About Microsoft

Microsoft (Nasdaq “MSFT” @microsoft) enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more.

About the Talkdesk partner ecosystem:

The Talkdesk global ecosystem represents a diverse network of best-in-class resellers, strategic alliance partners, cloud distributors, and technology vendors focused on providing a better way for organizations to create more meaningful and memorable moments with their customers. These partners support Talkdesk in helping customers across industries and around the world deliver customer experiences that build trust and loyalty.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye